Full text is available at the source.
Abstract
The study evaluates the association between glucagon-like peptide-1 (GLP-1) therapy and small-bowel transit time during capsule endoscopy.
- GLP-1 is a hormone involved in regulating blood sugar and digestion.
- Small-bowel transit time refers to how long it takes food to move through the small intestine.
- Capsule endoscopy is a non-invasive procedure that captures images of the small intestine.
- The potential link between GLP-1 therapy and altered small-bowel transit time is being explored.
- Findings may provide insights into how GLP-1 therapy affects digestive processes.
Simplified